K+ channel blockade impairs remyelination in the cuprizone model

GLIA

Volumn 48, Issue 2, 2004, Pages 156-165

  Bacia, Andrzej ^a   Wollmann, Robert ^a   Soliven, Betty ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Demyelinating diseases; Ion channel blockers; Myelination; Oligodendrocytes

Indexed keywords

4 AMINOPYRIDINE; CUPRIZONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RIP; MYELIN BASIC PROTEIN; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; ELECTRON MICROSCOPY; MALE; MOUSE; NERVE REGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; SPINAL CORD INJURY; STEM CELL;

4-AMINOPYRIDINE; ANIMALS; ASTROCYTES; CHELATING AGENTS; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GLIOSIS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN BASIC PROTEINS; MYELIN SHEATH; NERVE REGENERATION; NEUROGLIA; OLIGODENDROGLIA; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; STEM CELLS;

EID: 9144274528     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20067     Document Type: Article

References (51)

1. Allamargot C, Pouplard-Barthelaix A, Fressinaud C. 2001. A single intracerebral microinjection of platelet-derived growth factor (PDGF) accelerates the rate of remyelination in vivo. Brain Res 918:28-39.
2. Armstrong RC, Le TQ, Frost E, Borke RC, Vana AC. 2002. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574-8585.
3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP-Y. 2001. TNF-alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neurosci 4:1116-1122.
4. Attali B, Wang N, Kolot A, Sobko A, Cherepanov V, Soliven B. 1997. Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J Neurosci 17:8234-8245.
5. Barres BA, Schmid R, Sendtner M, Raff MC. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
6. + channels improves experimental autoimmune encephalomyelitis and inhibits T Cell activation. J Immunol 166:936-944.
7. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 98:13942-13947.
8. Bever CT Jr., Young D, Anderson P, Krumholz A, Conway K, Leslie J, Eddington N, Plaisance K, Panitch H, Dhib-Jalbut S. 1994. The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo controlled, double blind, concentration controlled, crossover trial. Neurology 44:1054-1059.
9. Borges K, Wolswijk G, Ohlemeyer C, Kettenmann H. 1995. Adult rat optic nerve oligodendrocyte progenitor cells express a distinct repertoire of voltage- and ligand-gated ion channels. J Neurosci Res 40:591-605.
10. Bostock H, Sears T, Sherratt R. 1981. The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibers. J Physiol 313:301-315.
11. Carroll WM, Jennings AR. 1994. Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 117:563-578.
12. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp B. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404-6412.
13. 1/S phase progression of the cell cycle. Proc Natl Acad Sci USA 99:2350-2355.
14. Davis FA, Stefoski D, Rush J. 1990. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol 27: 186-192.
15. Friedman B, Hockfield S, Black JA, Woodruff KA, Waxman SG. 1989. In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, Rip. Glia 2:380-390.
16. + channel block. J Neurosci 16:2659-2670.
17. Gao X, Gillig T, Ye P, D'Ercole J, Matsushima G, Popko B. 2000. Interferon-gamma protects against cuprizone-induced demyelination. Mol Cell Neurosci 16:338-349.
18. Gensert J, Goldman J. 1996. In vivo characterization of endogenous proliferating cells in adult rat subcortical white matter. Glia 17:39-51.
19. Hida H, Nagano S, Takeda M, Soliven B. 1999. Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes. J Neurosci 19:7458-7467.
20. Jones L, Yamaguchi Y, Stallcup W, Tuszynski M. 2002. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22:2792-2803.
21. Keirstead HS, Levine JM, Blakemore WF. 1998. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22:161-170.
22. Komoly S, Hudson LD, Webster HD, Bondy CA. 1992. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 89:1894-1898.
23. Labat-Moleur F, Guillermet C, Lorimier P, Robert C, Lantuejoul S, Brambilla E, Negoescu A 1998. TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. J Histochem Cytochem 46:327-334.
24. Levine J, Reynolds R, Fawcett J. 2001. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24:39-47.
25. Levine JM, Stincone F, Lee Y-S. 1993. Development and differentiation of glial precursor cells in the rat cerebellum. Glia 7:307-321.
26. Ludwin SK. 1978. Central nervous system demyelination and remyelination in the mouse. Lab Invest 39:597-612.
27. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK. 2000. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20:5703-5708.
28. Mathie A, Wooltorton J, Watkins C. 1998. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol 30:13-24.
29. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
30. Nait-Oumesmar B, Vignais L, Van Evercooren AB. 1997. Developmental expression of platelet-derived growth factor α-receptor in neurons and glial cells of the mouse CNS. J Neurosci 17:125-139.
31. Nait-Oumesmar B,. Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Van Evercooren AB. 1999. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 11:4357-4366.
32. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB. 1996. Co-localization of NG2 proteoglycan and PDGFα-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43:299-314.
33. + glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol 58: 1113-1124.
34. + glial cells are distinct from resting and activated microglia. J Neurosci Res 48:299-312.
35. Oderfeld-Nowak B, Bacia A. 1994. Expression of astroglial nerve growth factor in damaged brain. Acta Neurobiol Exp 54:73-80.
36. Picard-Riera N, Decker L, Delarasse C, Goude K, Nait-Oumesmar B, Liblau R, Pham-Dinh D, van Evercooren AB. 2002. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci USA 99:13211-13216.
37. Prineas JW, McDonald W. 1997. Demyelinating diseases. In: Graham D, Lantos P, editors. Greenfield's neuropathology. New York: Oxford University Press, p 813-896.
38. Raine C. 1994. Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 53: 328-337.
39. Redwine J, Armstrong RC. 1998. In vivo proliferation of oligodendrocyte progenitors expressing PDGF-alphaR during early remyelination. J Neurobiol 37:413-428.
40. Rodriguez M, Sheithauer B. 1994. Ultrastructure of multiple sclerosis. Ultrastruct Pathol 18:3-13.
41. Roy ML, Saal D, Perney T, Sontheimer H, Waxman SG, Kaczmarek LK. 1996. Manipulation of the delayed rectifier Kv1.5 potassium channel in glial cells by antisense oligodeoxynucleotides. Glia 18: 177-184.
42. Schmidt K, Eulitz D, Veh RW, Kettenmann H, Kirchhoff F. 1999. Heterogeneous expression of voltage-gated potassium channels of the shaker family (Kv1) in oligodendrocyte progenitors. Brain Res 843:145-160.
43. Shi R, Blight A. 1997. Differential effects of low and high concentrations on axonal conduction in normal and injured spinal cord. Neuroscience 77:553-562.
44. Shrager P, Novakovic SD. 1995. Control of myelination, axonal growth, and synapse formation in spinal cord explants by ion channels and electrical activity. Dev Brain Res 88:68-78.
45. Smart SL, Bosma MM, Tempel BL. 1997. Identification of the delayed rectifier Kv1.6 in cultured astrocytes. Glia 20:127-134.
46. Smith K, Felts P, John G. 2000. Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension. Brain 123:171-184.
47. Soliven B, Ma L, Bae H, Attali B, Sobko A, Iwase T. 2003. PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors. Am J Physiol (Cell Physiol) 284:C85-C93.
48. Targ EF, Kocsis JD. 1985. 4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve. Brain Res 328:358-361.
49. vanDiemen H, Polman C, vanDongen T, vanLoenen A, Nauta J, Taphoorn M, vanWalbeek H, Koetsier J. 1992. The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study. Ann Neurol 32: 123-130.
50. Yamaguchi S, Rogawski M. 1992. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res 11:9-16.
51. Yuan X, Chittajallu R, Belachew S, Anderson S, McBain C, Gallo V. 2002. Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. J Neurosci Res 70:529-545.